| Name | Ethyl 3-amino-4-(4-benzyl-1-piperazinyl)benzoate |
|---|---|
| Synonyms |
MFCD06666140
Benzoic acid, 3-amino-4-[4-(phenylmethyl)-1-piperazinyl]-, ethyl ester Ethyl 3-amino-4-(4-benzyl-1-piperazinyl)benzoate |
| Description | DCLX069 is a selective protein arginine methyltransferase 1 (PRMT1) inhibitor with an IC50 value of 17.9 µM. DCLX069 shows less active against PRMT4 and PRMT6. DCLX069 has anticancer effects[1]. |
|---|---|
| Related Catalog | |
| Target |
PRMT1:17.9 μM (IC50) |
| In Vitro | DCLX069 (12.5-100 µM) effectively blocks cell proliferation in breast cancer, liver cancer and acute myeloid leukemia cell lines (MCF7, HepG2, and THP1 cells) in a concentration-dependent manner[1]. |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 515.9±50.0 °C at 760 mmHg |
| Molecular Formula | C20H25N3O2 |
| Molecular Weight | 339.431 |
| Flash Point | 265.8±30.1 °C |
| Exact Mass | 339.194672 |
| LogP | 2.63 |
| Vapour Pressure | 0.0±1.3 mmHg at 25°C |
| Index of Refraction | 1.611 |